Janssen, L.P.'s INVEGA Approved By FDA As New Treatment For Schizophrenia TITUSVILLE, N.J., Dec. 20 /PRNewswire/ -- First Oral Extended Release Medication to Treat Schizophrenia. The U.S. Food and ...

INVEGA® receives European Commission approval to extend its adult indication for treatment of schizophrenia to include adolescents aged 15 years and older BEERSE, Belgium, 4 June 2014: Janssen-Cilag ...

Invega Hafyera (paliperidone palmitate) is a prescription drug that’s used to treat schizophrenia. It’s given as an injection into your muscle by your doctor or another healthcare professional. Invega ...

Lupin is offering paliperidone extended-release tablets in dosage strengths of 1.5 mg, 3 mg, 6 mg and 9 mg. The medication is the generic of Janssen’s Invega.

Johnson & Johnson has had little trouble keeping sales from its Invega portfolio of long-acting antipsychotic injectables in the billions. Now, it's angling for approval of an even more durable ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. INVEGA HAFYERA contains the active ingredient paliperidone palmitate.